Hydromer, a global leader in innovative coating technologies, is proud to announce its pivotal role in assisting leading medical device manufacturers in transitioning away from PFAS-based coatings.
CONCORD, N.C., Jan. 21, 2025 /PRNewswire-PRWeb/ -- Hydromer, Inc. (the "Company") Hydromer, a global leader in innovative coating technologies, is proud to announce its pivotal role in assisting leading medical device manufacturers in transitioning away from PFAS-based coatings. Often referred to as "forever chemicals," PFAS materials, including PTFE, are under growing scrutiny for their harmful environmental and health impacts.
As regulatory bodies worldwide propose restrictions and bans on PFAS, medical device companies and manufacturers face the challenge of finding effective, sustainable alternatives. Hydromer is at the forefront of this transformation, offering hydrophilic coatings that are free of PFAS materials. These coatings not only eliminate the environmental risks associated with "forever chemicals" but also deliver superior performance for medical devices, ensuring patient safety remains a top priority.
Legacy Innovations with Hydrophilic Coating Solutions
Hydromer's PFAS-free hydrophilic coatings are designed to provide medical device manufacturers with a seamless transition from traditional PFAS-based coatings. These advanced coatings offer exceptional lubricity, durability, and biocompatibility, ensuring devices perform optimally while adhering to evolving environmental standards.
"The industry is at a turning point," said Mike Torti, CEO of Hydromer. "We are proud to be a trusted partner for medical device manufacturers as they navigate this complex transition. Our hydrophilic coatings provide a seamless, sustainable solution, enabling manufacturers to meet evolving regulations while maintaining the highest standards of product quality."
Hydromer is currently collaborating with major industry players on R&D projects aimed at implementing PFAS-free solutions. While these engagements are in the early stages and do not involve formal agreements, they reflect the growing interest and urgency from leading companies to adopt sustainable coating technologies.
Responding to Regulatory and Public Pressure
With increasing awareness of the toxicity and persistence of PFAS in the environment, regulators are stepping up their efforts to curb the use of these harmful substances. Hydromer's proactive approach to collaborate with medical device manufacturers ensures that its customers stay ahead of compliance requirements and public expectations.
"We understand the challenges medical device companies face in moving away from established materials," added Torti. "Our goal is to provide not only a superior product but also guidance through this transition to ensure our partners meet their regulatory obligations without compromising device performance."
Targeting New Partnerships and Supporting Existing Clients
While Hydromer continues to serve its existing clients, this initiative is also focused on engaging new customers in need of PFAS-free coating solutions. The company is actively assisting current clients in transitioning their products to PFAS-free alternatives, ensuring a smooth shift to sustainable coatings without compromising quality or performance. By offering comprehensive support throughout the transition process, Hydromer is helping both new and existing partners stay compliant with upcoming regulations.
Hydromer remains committed to innovation and sustainability, continuously investing in research and development to expand its portfolio of environmentally friendly coatings. The company is actively monitoring the regulatory landscape and adapting its solutions to help partners stay compliant and competitive.
For more information on how Hydromer is leading the charge toward PFAS-free medical coatings, please visit www.hydromer.com or contact us at (800) 326-5976.
About Hydromer
Hydromer, Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for a wide variety of applications. We are domiciled in Concord, NC. Our customers are located across the United States, Europe and Asia-Pacific. Our facilities are U.S. Food and Drug Administration (FDA), Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001 compliant. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. We manage numerous global B2B services such as coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and hold many patents worldwide, including those with anti-microbial, anti-fog, anti-frost, condensation-controlling, hydrophilic, and thromboresistant coating applications.
Forward-Looking Statements
This press release contains forward-looking statements that are based on Hydromer's current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Media Contact
Mike Torti, Hydromer, Inc., 1 800-326-5976, [email protected]
SOURCE Hydromer, Inc.
Share this article